Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

424B5

SEC Filing Details

Document Details

Form
Filing Date
Jan 23, 2018
Document Date
Jan 23, 2018
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved